Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc
Open accessThe DOI matches its Crossref record.
Abstract
ZnT2 (zinc transporter-2) expression is restricted to tissues with unique zinc requirements such as mammary and prostate glands. We previously determined that ZnT2 plays a major role in zinc export from mammary glands, as women with a mutation in the gene encoding ZnT2 (SLC30A2) had an ∼75% reduction in milk zinc concentration. Two distinct human ZnT2 isoforms (∼42 and 35 kDa) are predicted to result from alternative splicing of SLC30A2. We examined the localization and function of each ZnT2 isoform, in cells generated to express ZnT2–HA (haemagglutinin) fusion proteins. The 42 kDa isoform was localized primarily to the endosomal/secretory compartment and overexpression resulted in increased zinc vesicularization. In contrast, the 35 kDa isoform is associated with the plasma membrane. Importantly, zinc transport was higher in cells over-expressing each isoform, indicating that both proteins are functional. Endogenous expression of the secretory vesicle-associated ZnT2 isoform predominates in mammary cells and expression is higher in secreting cells, whereas the smaller isoform plays a minor role in zinc export, directly reflecting the secretory function of the mammary gland. Together our data shed further light on the complex integration of cellular zinc transport mechanisms, which may be facilitated by multiple isoforms of specific zinc transporters with unique cellular functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Kambe, T., Tsuji, T., Hashimoto, A., & Itsumura, N. (2015) · Physiological Reviews · doi:10.1152/physrev.00035.2014 · Cited by 1,158
Function of alternative splicing
Kelemen, O., Convertini, P., Zhang, Z., Wen, Y., Shen, M., Falaleeva, M., & Stamm, S. (2013) · Gene · doi:10.1016/j.gene.2012.07.083 · Cited by 743
“SLC30A2 (solute carrier family 30 (zinc transporter), member 2) The shorter isoform is localized on cytoplasm membrane and the longer isoform is primarily localized to the endosomal compartment (Lopez and Kelleher, 2009)”
Huang, L., & Tepaamorndech, S. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.05.008 · Cited by 343
The emerging role of zinc transporters in cellular homeostasis and cancer
Bafaro, E., Liu, Y., Xu, Y., & Dempski, R. E. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.29 · Cited by 307
Role of zinc in health and disease
Stiles, L. I., Ferrao, K., & Mehta, K. J. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01302-6 · Cited by 275
“…n t i s p r i m a r il y l o ca t e d on t h e m e m b r a n e s o f v e s i c l e s , i n c l ud i ng e ndo s o m e s a nd l y s o s o m e s [ 44 , 48 ] a s w e ll a s z y m og e n g r a nu l e s i n p a n c r ea ti c ac i n a r ce ll s a nd t h e i nn e r m it o c hond r i a l m e m b r a n e i…”
BackgroundZinc in Specialized Secretory Tissues: Roles in the Pancreas, Prostate, and Mammary Gland
Kelleher, S. L., McCormick, N. H., Velasquez, V., & Lopez, V. (2011) · Advances in Nutrition · doi:10.3945/an.110.000232 · Cited by 263
Self-citationNishito, Y., & Kambe, T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010227 · Cited by 117
“ZNT1 is N-glycosylated on the Asn299 residue, which neither affects the ability to confer resistance against high zinc levels nor the subcellular localization of ZNT1 We first confirmed whether our anti-ZNT1 mAb, which was generated against the C-terminal cytosolic portion of the protein, specifically detects ZNT1 usi…”
BackgroundInfluential
Metadata
- Authors
- Lopez, V., & Kelleher, S. L.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2009-07-29
- Volume
- 422
- Issue
- 1
- Pages
- 43-52
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1970611977
- Cited by
- 100
- References
- 0
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.